Search Results Search Sort by RelevanceMost Recent Case and Commentary Mar 2005 Transition of Care Jonathan Spahr, MD and Don Hayes, Jr, MD Virtual Mentor. 2005;7(3):218-221. doi: 10.1001/virtualmentor.2005.7.3.ccas3-0503. State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. AMA Code Says Nov 2016 AMA Code of Medical Ethics’ Opinions Related to Discrimination and Disparities in Health Care Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics opinions related to discrimination and disparities in health care. AMA J Ethics. 2016;18(11):1095-1097. doi: 10.1001/journalofethics.2016.18.11.coet1-1611.
Case and Commentary Mar 2005 Transition of Care Jonathan Spahr, MD and Don Hayes, Jr, MD Virtual Mentor. 2005;7(3):218-221. doi: 10.1001/virtualmentor.2005.7.3.ccas3-0503.
State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
AMA Code Says Nov 2016 AMA Code of Medical Ethics’ Opinions Related to Discrimination and Disparities in Health Care Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics opinions related to discrimination and disparities in health care. AMA J Ethics. 2016;18(11):1095-1097. doi: 10.1001/journalofethics.2016.18.11.coet1-1611.